Clinical Trial: Topical AS101 for Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Study Status: Completed
Recruit Status: Unknown status
Study Type: Interventional
Official Title: Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women
Brief Summary: The primary objective of this study is to assess the safety and efficacy of topical AS101 as treatment for Female Androgenetic Alopecia (FAGA) in menopause women.
Detailed Summary:
Sponsor: Rabin Medical Center
Current Primary Outcome: hair density
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Hair diameter, anagen/telogen ratio and hair growth rate,Global photographic assessment according to Female-Ludwig scale,
- Self-administered satisfaction questionnaire
Original Secondary Outcome: Same as current
Information By: Rabin Medical Center
Dates:
Date Received: January 2, 2007
Date Started:
Date Completion:
Last Updated: January 3, 2007
Last Verified: December 2006